Literature DB >> 19237681

Cigarette smoking abolishes ischemic preconditioning-induced augmentation of endothelium-dependent vasodilation.

Shuji Nakamura1, Masashi Kimura, Chikara Goto, Kensuke Noma, Masao Yoshizumi, Kazuaki Chayama, Yasuki Kihara, Yukihito Higashi.   

Abstract

We have shown recently that repetition of ischemic preconditioning stimulus augments endothelium-dependent vasodilation in forearm circulation of healthy subjects through increases in NO production and the number of circulating progenitor cells under a local condition. The purpose of this study was to evaluate the "late" effect of ischemic preconditioning on endothelial function in smokers. Ischemic preconditioning was induced by upper-limb ischemia 6 times a day for 1 month. We evaluated forearm blood flow responses to acetylcholine and sodium nitroprusside before and after ischemic preconditioning stimulus in 15 male smokers (27+/-7 years) and 15 male nonsmokers (26+/-5 years). Forearm blood flow was measured by using a strain-gauge plethysmography. The ischemic preconditioning stimulus resulted in significant increases in the circulating level of circulating progenitor cells from 1029+/-261 to 1232+/-341 mL (P=0.02), cell migration response to vascular endothelial growth factor from 38+/-16 to 52+/-17 per high-power field (P=0.02), and forearm blood flow response to acetylcholine from 25.1+/-5.2 to 32.4+/-6.6 mL/min per 100 mL of tissue (P=0.002) in nonsmokers, but these did not change in the smoker group. The forearm blood flow responses to sodium nitroprusside before and after the ischemic preconditioning stimulus were similar. Intra-arterial infusion of N(G)-monomethyl-l-arginine, an NO synthase inhibitor, completely eliminated the ischemic preconditioning stimulus-induced augmentation of forearm blood flow responses to acetylcholine in nonsmokers. These findings suggest that repetition of ischemic preconditioning stimulus may be a simple, safe, and feasible therapeutic technique for endothelial protection of peripheral vessels. However, smoking abolishes ischemic preconditioning stimulus-induced augmentation of endothelium-dependent vasodilation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237681     DOI: 10.1161/HYPERTENSIONAHA.108.126078

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

1.  Endothelium-dependent vasodilation is associated with exercise capacity in smokers and non-smokers.

Authors:  Kevin S Heffernan; Richard H Karas; Eshan A Patvardhan; Jeffrey T Kuvin
Journal:  Vasc Med       Date:  2010-04       Impact factor: 3.239

Review 2.  The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection.

Authors:  Derek J Hausenloy; William Chilian; Filippo Crea; Sean M Davidson; Peter Ferdinandy; David Garcia-Dorado; Niels van Royen; Rainer Schulz; Gerd Heusch
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

Review 3.  Effects of Remote Ischemic Conditioning on Cerebral Hemodynamics in Ischemic Stroke.

Authors:  Chen Qin; Xiuli Yan; Hang Jin; Ruyi Zhang; Yaode He; Xin Sun; Yihe Zhang; Zhen-Ni Guo; Yi Yang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-23       Impact factor: 2.570

4.  Critical role of exogenous nitric oxide in ROCK activity in vascular smooth muscle cells.

Authors:  Tatsuya Maruhashi; Kensuke Noma; Yumiko Iwamoto; Akimichi Iwamoto; Nozomu Oda; Masato Kajikawa; Takeshi Matsumoto; Takayuki Hidaka; Yasuki Kihara; Kazuaki Chayama; Ayumu Nakashima; Chikara Goto; James K Liao; Yukihito Higashi
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

Review 5.  Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease.

Authors:  Caterina Oriana Aragona; Egidio Imbalzano; Federica Mamone; Valentina Cairo; Alberto Lo Gullo; Angela D'Ascola; Maria Adriana Sardo; Michele Scuruchi; Giorgio Basile; Antonino Saitta; Giuseppe Mandraffino
Journal:  Stem Cells Int       Date:  2015-12-29       Impact factor: 5.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.